NB |
Neuroblastoma |
CCCG |
the Chinese Children’s Cancer Group |
COG |
the Children’s Oncology Group |
INSS |
the International Neuroblastoma Staging System |
INRC |
the International Neuroblastoma Response Criteria |
SCT |
Stem Cell Transplantation |
Bu/Mel |
Bulsufan/Melphalan |
CEC |
Carboplatin, Etoposide, and Cyclophosphamide |
EFS |
Event-Free Survival |
OS |
Overall Survival |
CEM |
Carboplatin, Etoposide, and Melphalan |
MM |
Bulsufan/Melphalan |
INPC |
International Neuroblastoma Pathology
Classification |
FH |
Favorable Histology |
UH |
Unfavorable Histology |
NSE |
Neuron-Specific Enolase |
LDH |
Lactate Dehydrogenase |
IDRFs |
Image-defined Risk Factors |
CR |
Complete Remission |
VGPR |
Very Good Partial Remission |
PR |
Partial Remission |